Veterinärmedizinische Universität Wien Forschungsinformationssystem VetDoc

Grafischer Link zur Startseite der Vetmeduni Vienna

Gewählte Publikation:

Publikationstyp: Zeitschriftenaufsatz
Dokumenttyp: Originalarbeit

Jahr: 2017

AutorInnen: Mucha, M; Virac, I; Lang, C; Wittek, K; Tichy, A; Bockstahler, B

Titel: Treatment of the clinical symptoms caused by osteoarthritis using nuclear magnetic resonance (MBST (R)) in dogs - a randomized trial

Titelvariante: Behandlung der durch Osteoarthrose bedingten klinischen Symptome mittels Kernspinresonanztherapie (MBST®) beim Hund – eine randomisierte Studie

Quelle: Wien Tierarztl Monat. 2017; 104(3-4): 109-115.

Autor/innen der Vetmeduni Vienna:

Bockstahler Barbara
Mucha Marion
Tichy Alexander
Wittek Kathleen

Beteiligte Vetmed-Organisationseinheiten
Universitätsklinik für Kleintiere, Klinische Abteilung für Kleintierchirurgie
Plattform Bioinformatik und Biostatistik

Canine osteoarthritis (OA) is frequently encountered in dogs. Various methods are available to treat the associated pain, stiffness and lameness. A recently developed method involves the use of nuclear magnetic resonance (NMR), in which a permanent magnetic field is combined with an interfering field. A double-blinded randomized trial was performed to evaluate whether nuclear magnetic resonance treatment (MBST) improved the clinical signs of dogs suffering from osteoarthritis directly and three and six months after treatment. Fifteen dogs received NMR treatment (TG) and 15 received a placebo (PG) over a period of nine days. Symmetry indices of peak vertical force and vertical impulse, lameness and pain score, drop-out, additional pain medication and physical therapy during the course of the study were recorded. An individual score was calculated for each dog to evaluate the overall effectiveness of treatment (OTE) at the three time points. The TG showed significantly improved symmetry indices for vertical impulse and lameness scores at three months after treatment. The findings suggest that NMR had positive effects on the clinical signs of OA in dogs at three months after therapy.

© Veterinärmedizinische Universität Wien Hilfe und DownloadsErklärung zur Barrierefreiheit